Bhat, Smillie join peerVue team

TriMed Staff | | Health Imaging | Artificial Intelligence
peerVue LLC has announces the appointment of Sandeep Bhat and Richard Smillie to its sales team. Bhat's role will be sales of peerVue's flagship digital teaching file product line, whereas Smillie will work to develop strategic relationships and also support sales. The new team members continue the steady development of the peerVue organization and add more than 35 years of collective experience to the peerVue organization.
    
Bhat's background includes experience in overseeing advanced imaging clinical trials, and  Smillie was chosen because of his industry knowledge and network of relationships, which peerVue hopes will empower the execution of its strategies, said Kyle Lawton, CEO & Director of Business Development in a release.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.